4:59 PM
 | 
Jan 10, 2013
 |  BC Extra  |  Financial News

GSK investing in new Sanderling fund

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will contribute $50 million to Sanderling Ventures' new $250 million Sanderling...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >